The EU-MDR Article 16 No. 2 provide some guidance which should be considered here:
.... the following shall not be considered to be a modification of a device that could affect its compliance with the applicable requirements:
(a) provision, including translation, of the information supplied by the manufacturer, in accordance with Section 23 of Annex I, relating to a device already placed on the market and of further information which is necessary in order to market the device in the relevant Member State;
(b) changes to the outer packaging of a device already placed on the market, including a change of pack size, if the repackaging is necessary in order to market the device in the relevant Member State and if it is carried out in such conditions that the original condition of the device cannot be affected by it. In the case of devices placed on the market in sterile condition, it shall be presumed that the original condition of the device is adversely affected if the packaging that is necessary for maintaining the sterile condition is opened, damaged or otherwise negatively affected by the repackaging. 5.5.2017 L 117/29 Official Journal of the European Union
For me this gives a hint that the activities you mentioned are inline with the CE marking as long as you provide the original information of the manufacturer and the "original condition" of the device is not affected.
Anyhow this is the view of the EU-MDR it is more important how the TGA sees such activities - maybe your Australian representative can evaluate it.
BR
Frank
------------------------------
Frank Wilmerstaedt
General Manager QA/RA
Hamburg, Germany
------------------------------
Original Message:
Sent: 19-Feb-2020 00:05
From: Anonymous Member
Subject: Reworking CE marked product in Australia
This message was posted by a user wishing to remain anonymous
Dear RAPS community,
This is a question relating to Australian medical devices regulations. Are sponsors allowed to re-work a CE mark medical device i.e. open a medical device packaging to remove a global IFU and replace it with an Australian specific CE mark or would this be considered voiding the CE marking?
For this particular product the sterile barrier would not be broken as the IFU sits on top of further inner packaging. However the product is CE marked in its original outer packaging.
Would a sponsor be considered to be a manufacturer and therefore need a manufacturing licence from TGA in order to perform the task described above? Where in the regulations can I find this information?
Many thanks and kind regards.